Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study
Authors:
- Alberto PapiAPAlberto Papi
- Konstantinos KostikasKKKonstantinos Kostikas
- Jadwiga A. WedzichaJWJadwiga A. Wedzicha
- Claus F. VogelmeierCVClaus F. Vogelmeier
- Nicolas RocheNRNicolas Roche
- Steven ShenSSSteven Shen
- Donald BanerjiDBDonald Banerji
- Robert FogelRFRobert Fogel
- Francesco PatalanoFPFrancesco Patalano
- Kenneth R. ChapmanKCKenneth R. Chapman
- 1 May 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 197 (9) , 1223-1226
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPDInternational Journal of Chronic Obstructive Pulmonary Disease, 2017
- Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline CountsAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME TrialAmerican Journal of Respiratory and Critical Care Medicine, 2017
- LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysisInternational Journal of Chronic Obstructive Pulmonary Disease, 2017
- Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPDNew England Journal of Medicine, 2016
- Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2015